A 3-month-delayed treatment with anatabine improves chronic outcomes in two different models of repetitive mild traumatic brain injury in hTau mice

Abstract To date, an overwhelming number of preclinical studies have addressed acute treatment in mild TBI (mTBI) and repetitive mTBI (r-mTBI), whereas, in humans, there often exists a significant time gap between the injury and the first medical intervention. Our study focused on a delayed treatmen...

Full description

Bibliographic Details
Main Authors: Alexander Morin, Benoit Mouzon, Scott Ferguson, Daniel Paris, Nicole Saltiel, Mackenzie Browning, Mike Mullan, Fiona Crawford
Format: Article
Language:English
Published: Nature Publishing Group 2021-04-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-87161-7